Serum soluble transferrin receptor concentration as a biomarker of erythropoietic activity: surrogate marker of adequate transfusion in adult Beta-thalassaemia intermedia patients

Serum soluble transferrin receptor concentration as a biomarker of erythropoietic activity: surrogate marker of adequate transfusion in adult Beta-thalassaemia intermedia patients

Management of Beta (β)-thalassaemia intermedia in contrast to β-thalassaemia major patients has no clear guidelines as to indicators of adequate transfusion. Regular blood transfusion suppresses bone marrow erythropoietic activity. Serum soluble transferrin receptor (sTfR) concentration is a marker...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Chellappah Thambiah, Subashini, George, Elizabeth, Umar, Nor Aini, Sathar, Jameela, Hambali, Zarida, Abu Bakar, Mokhtar
Format:	Artykuł
Język:	English English
Wydane:	Faculty of Medicine and Health Sciences, Universiti Putra Malaysia 2013
Dostęp online:	http://psasir.upm.edu.my/id/eprint/29695/1/Serum%20Soluble%20Transferrin%20Receptor%20Concentration%20as%20a%20Biomarker%20of%20Erythropoietic.pdf http://psasir.upm.edu.my/id/eprint/29695/7/Serum%20soluble%20transferrin%20receptor%20concentration%20as%20a%20biomarker%20of%20erythropoietic%20activity.pdf

Podobne zapisy

Alpha thalassaemia is associated with increased soluble transferrin receptor levels.
od: Rees, D, i wsp.
Wydane: (1998)

THALASSAEMIA INTERMEDIA : AN UPDATE
od: Maria Domenica Cappellini, i wsp.
Wydane: (2009-06-01)

THALASSAEMIA INTERMEDIA : AN UPDATE
od: Ali Taher, i wsp.
Wydane: (2009-08-01)

Effects of transfusion and splenectomy on globin chain expression in NTDT HbE/β-thalassaemia
od: Lim, Wai Feng, i wsp.
Wydane: (2021)

Haemoglobin Adana in alpha thalassaemia intermedia in the Malaysian population
od: Lee, Tze Yan
Wydane: (2017)

Monoclonal gammopathy with systemic amylodosis: an evaluation of diagnostic elements
od: Chellappah Thambiah, Subashini, i wsp.
Wydane: (2011)

Revitalise your knowledge thru’ clinical data interpretation
od: Hambali, Zarida, i wsp.
Wydane: (2013)

Haematologic profile of haemoglobin constant spring and its co-inheritance with alpha and beta thalassaemia among form four students in Negeri Sembilan
od: Nahanthiran, Subithira, i wsp.
Wydane: (2022)

Determination of the 99th percentile upper reference limit for highsensitivity cardiac troponin I in Malaysian population
od: Lim, Say Min, i wsp.
Wydane: (2017)

Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency
od: Dagmar Pospisilova, i wsp.
Wydane: (2014-07-01)

Compound heterozygous beta thalassaemia and hereditary persistence of foetal haemoglobin presenting as thalassemia intermedia
od: Rohinie Warushahennadi, i wsp.
Wydane: (2023-01-01)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
od: Eleni Gavriilaki, i wsp.
Wydane: (2018-10-01)

Is blood transfusion therapy the ideal treatment for ?-Thalassemia Intermedia?
od: Katerina Constantinou
Wydane: (2014-08-01)

Clinical presentation of congenital adrenal hyperplasia in selected multiethnic paediatric population
od: Chellappah Thambiah, Subashini, i wsp.
Wydane: (2015)

Transfusion transmitted malaria in a thalassaemia major patient
od: Anuar, Nur Aliaa, i wsp.
Wydane: (2020)

Malaysian socio-demographic characteristics, mean haemoglobin levels and BMI distribution of the monthly transfused group (MTG) and non-monthly transfused group (NMTG) thalassemia patients
od: Mohammed Ibraheem, Shahad, i wsp.
Wydane: (2022)

EXTREME NORMOBLASTOSIS IN A THALASSAEMIA INTERMEDIA PATIENT POST-SPLENECTOMY: THE ROLE OF FLOW CYTOMETRY IN DIAGNOSIS AND MANAGEMENT
od: İdil Yürekli, i wsp.
Wydane: (2024-12-01)

Progressive Paraparesis due to Extramedullary Haematopoiesis in Thalassaemia Intermedia Treated Successfully with Radiotherapy: A Case Report
od: Bithi Pal, i wsp.
Wydane: (2024-08-01)

Erythropoietic protoporphyria in pregnancy.
od: Madu, A, i wsp.
Wydane: (2006)

Congenital erythropoietic porphyria
od: M Kürkçüoğlu, i wsp.
Wydane: (1985-01-01)

Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment
od: Dahlui, M., i wsp.
Wydane: (2009)

Craniofacial And Dental Arches Characteristics In Transfusion Dependent Thalassaemia Patients
od: Fattah Toman, Heba Ahmed Abdel
Wydane: (2009)

Clinical Determinants of Cardiac Iron in Regularly Transfused Thalassemia Intermedia Patients
od: Antonella Meloni, PhD, i wsp.
Wydane: (2024-01-01)

Mayor Erythropoietic Response after Deferasirox Treatment in a Transfusion-Dependent Anemic Patient with Primary Myelofibrosis
od: Del Corso Lisette, i wsp.
Wydane: (2013-01-01)

Reduced soluble transferrin receptor concentrations in acute malaria in Vanuatu.
od: Williams, T, i wsp.
Wydane: (1999)

Establishing referance intervals for haematological parameters, soluble serum transferrin receptor and serum transferrin in a tertiary hospital in Malaysia
od: Hemalatha, S., i wsp.
Wydane: (2014)

Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia
od: Tan, Khian Aun, i wsp.
Wydane: (2019)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
od: Dimitrios Farmakis, i wsp.
Wydane: (2022-08-01)

Case series of homozygous and compound heterozygosity of Hb Malay, the diagnostic features and transfusion requirements
od: Amran, Hanizah Salwa, i wsp.
Wydane: (2017)

No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia
od: Raffaella Origa, i wsp.
Wydane: (2008-07-01)

A Rare Case of Alpha-Thalassaemia Intermedia in a Malay patient double heterozygous for a+-Thalassaemia and a mutation in a1 Globin Gene CD59 (GGC GAC)
od: George, E., i wsp.
Wydane: (2009)

A rare case of alpha-thalassaemia intermedia in a Malay patient double heterozygous for α+ –thalassaemia and a mutation in α1 globin gene CD59 (GGC → GAC)
od: George, Elizabeth, i wsp.
Wydane: (2009)

Prolonged neonatal jaundice with deranged thyroid function test
od: Choo, Jin Earn, i wsp.
Wydane: (2020)

Economic Analysis Of Transfusion Dependent Thalassaemia (Tdt) And Deferasirox Fct Efficiency In Malaysia
od: Wong, Jacqueline Hui Yi
Wydane: (2020)

Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Regularly Transfused Thalassemia Intermedia Patients
od: Antonella Meloni, PhD, i wsp.
Wydane: (2024-01-01)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
od: Antonella Meloni, i wsp.
Wydane: (2023-08-01)

Erythropoietic protoporphyria and early onset of cholestasis
od: Mani Jeh Khalili, i wsp.
Wydane: (2012-12-01)

Delineation of erythropoietic intermediates by flow cytometry
od: Kathleen E. McGrath
Wydane: (2024-12-01)

An assessment of three noncommercial DNA extraction methods from dried blood spots for beta-thalassaemia mutation identification.
od: Kartipan, S. N., i wsp.
Wydane: (2011)

Second generation of soluble transferrin receptor assay – consequences for the interpretation of the ‘Thomas plot’
od: Mirtschink Peter, i wsp.
Wydane: (2023-12-01)